UVa patients had access to important research treatments early in pandemic

… studies that included the recently approved drug remdesivir, other drugs, plasma containing COVID antibodies and treatment with stem cells.

The UVa study, and similar studies at other hospitals across the country, continued through the summer. On Oct. 22, the U.S. Food and Drug Administration approved the drug, also known by its trade name Veklury, for use in patients 12 and older and weighing at least 90 pounds.